Abdirasulova Zhainagul Abdirasulovna* and Atharva Ghadwaje
Human Papillomavirus (HPV) is one of the most not unusual sexually transmitted infections globally, affecting both women and men. HPV infections can result in quite a number of medical outcomes, from benign warts to doubtlessly life-threatening cancers. The virus is transmitted by intercourse or sexual hobby, and a few traces of HPV are categorized as excessive-danger, increasing the danger of developing cancers of the cervix, anus, penis, vagina, vulva, and oropharynx. Regardless of the availability of vaccines which could prevent HPV infections and decrease the danger of developing related cancers, the incidence of HPV-related cancers stays excessive, especially in low- and center-earnings international locations where entry to preventive measures and screening programs is limited. In this context, research performs a crucial position in information about the epidemiology, natural records, and clinical manifestations of HPV infections, as well as in developing effective prevention and management techniques. HPV infection is the maximum not unusual Sexually Transmitted Infection (STI) internationally, with an anticipated prevalence of around 11% among women. Despite the fact that maximum HPV infections are asymptomatic and remedy spontaneously inside years, some continual high-threat HPV infections can lead to cervical cancer and other genital cancers. As cervical most cancers are the fourth most common cancers in girls globally and are responsible for vast morbidity and mortality, HPV infection is a full-size public health situation. Vaccines in opposition to HPV have evolved and are effective in stopping HPV-associated cancers and other illnesses. But, the uptake of HPV vaccination and screening programs remains suboptimal in many countries, emphasizing the need for research to perceive the elements influencing HPV-related health behaviors and attitudes.
